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Abstract
INTRODUCTION—We examined associations between magnetic resonance imaging (MRI)
markers of cerebrovascular disease and neurodegeneration with mild cognitive impairment (MCI)
diagnosis at baseline and conversion from normal cognition to MCI at follow-up.

Author Manuscript

METHODS—Framingham Offspring participants underwent brain MRI and neuropsychological
assessment at baseline (n=1,049) and follow-up (n=561). Participants were classified at baseline
and at follow-up as cognitively normal or MCI using sensitive neuropsychological criteria. White
matter hyperintensity (WMH) volume, covert brain infarcts, hippocampal volume, and total
cerebral brain volume were quantified.
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RESULTS—Baseline measures of WMH and hippocampal volume were associated with MCI
status cross-sectionally and also with conversion from normal cognition to MCI at 6.5-year followup. Annualized change rates in total cerebral brain volume and hippocampal volume were
associated with conversion from normal cognition to MCI to follow-up.
DISCUSSION—Baseline WMH and hippocampal volume are markers that are both associated
with conversion from normal cognition to MCI, highlighting the role of both vascular lesions and
neurodegeneration in MCI.
Keywords
Mild cognitive impairment; MCI; MRI; Volumetric MRI; White matter hyperintensity;
Hippocampal volume
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INTRODUCTION
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Mild cognitive impairment (MCI) was conceived to represent a transitional state between
normal aging and Alzheimer’s disease (AD).1 MCI—even the amnestic subtype—has been
shown to be pathologically heterogeneous and often involve co-existing cerebrovascular and
neurodegenerative pathologies.2 In addition to established involvement of medial temporal
neurodegeneration in MCI,3 mounting evidence suggests that cerebrovascular changes
associated with small-vessel disease play an important role in risk and clinical expression of
MCI and AD.4–7 Small vessel cerebrovascular disease, as reflected by white matter
hyperintensities (WMH) (i.e., areas of increased signal on T2-weighted magnetic resonance
imaging [MRI]), and reduced hippocampal volume have both been associated with
decreased cognitive functioning in MCI8,9 and with faster rates of cognitive decline in MCI.5
Less is known about how MRI biomarkers of neurodegeneration and cerebrovascular disease
are associated with later conversion from normal cognition to MCI, particularly in
community-based cohorts.
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There is no consensus on one set of diagnostic criteria for MCI, leading to varying
definitional schemes and prevalence rates.10 Many studies have relied on one impaired score
(e.g., delayed free recall on story memory) to define impairment; however, reliance on a
single neuropsychological test as a marker of impairment is problematic given that a single
impaired score within a cognitive battery is common in neurologically normal adults.11
Research has emerged suggesting that actuarial neuropsychological criteria utilizing
comprehensive neuropsychological protocols to assess a wide range of cognitive abilities
beyond memory improves diagnostic rigor.12 Our previous work using actuarial criteria to
diagnosis MCI suggest that two impaired scores, defined as <1 SD below normative
expectations, within a cognitive domain10 bolsters associations between MCI status and
biomarkers while decreasing false positive errors compared with more conventional
approaches.12
In the current study, we examined associations of MRI markers of cerebrovascular disease
(WMH volume, covert brain infarcts) and neurodegeneration (hippocampal volume, total
cerebral volume) with MCI diagnosis using actuarial neuropsychological criteria in the
Framingham Offspring Cohort. In addition, we examined the extent to which baseline MRI
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markers are associated with conversion to MCI and the degree to which change in MRI
markers from baseline to follow-up is associated with conversion to MCI. Given the wellestablished involvement of medial temporal lobe structures in MCI and AD, we expected
that hippocampal volume would be associated with MCI status. Considering growing
evidence of the role of small-vessel cerebrovascular disease in MCI and AD5,13, we
additionally hypothesized that WMH volume would also be associated with conversion to
MCI.

METHODS
Participants

Author Manuscript

The Framingham Heart Study (FHS) is a community-based, prospective study initiated in
1948 to identify cardiovascular disease risk factors. Participants in the current study were
members of the Offspring Cohort, which includes biological children of the original FHS
cohort and offspring spouses (n=5,124) who have undergone health examinations
approximately every 4 years since 1971. The present analysis is based on the 3,539
participants who attended the 7th Offspring examination. As part of an ancillary study,
participants were invited to undergo neuropsychological assessment and brain MRI (1999–
2005). 2,551 participants who attended the 7th examination also underwent
neuropsychological assessment. As MCI prevalence is low in younger adults, we restricted
our sample to the 1,422 participants aged ≥60 years at the time of neuropsychological
testing. Of these, 1,215 participants also completed a MRI scan contemporaneously with the
7th examination cycle. We excluded participants with prevalent dementia (n=14), prevalent
stroke (n=28), or incomplete neuropsychological data (n=111), resulting in a final sample
size of 1,049 for cross-sectional analysis (supplementary figure 1).
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For longitudinal analysis, we included the 813 participants from the cross-sectional analysis
who were free of MCI at baseline. Of these, 665 participants underwent a repeat
neuropsychological test contemporaneously (within 1 year before and 5 years after) with the
8th Framingham Offspring examination cycle (2005–2008). We excluded participants due to
prevalent dementia (n=14), stroke (n=13), and other neurological conditions (n=9) at followup neuropsychological testing, and incomplete neuropsychological data (n=68), resulting in
a final sample size of 561 participants for longitudinal analysis (supplementary figure 2).
The protocol was approved by the Institutional Review Board of Boston University Medical
Center. All participants provided written informed consent.
Neuropsychological Assessment
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Standardized neuropsychological tests were administered at baseline and follow-up. Based
on the administered battery, there were three cognitive domains in which there were at least
two tests in that domain, which is necessary for MCI classification as described below and
as previously published in this sample.14 Memory was assessed with Wechsler Memory
Scale (WMS) Logical Memory delayed recall and recognition and Visual Reproduction
delayed recall and recognition. Executive Functioning/Attention/Processing Speed was
measured by Trail Making Tests A and B. Language was assessed with the Boston Naming
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Test and Similarities from the Wechsler Adult Intelligence Scale. Neuropsychological tests
scores were regressed onto age and education within gender. Residuals from these
regressions were standardized to have a mean of zero and a standard deviation of one using
z-score transformations.
MCI Classification
Participants were classified as normal or MCI according to comprehensive
neuropsychological criteria that operationalizes impairment as performance falling greater
than one standard deviation below normative expectations on at least two measures within a
cognitive domain.10 Participants were classified as Amnestic MCI when memory was
impaired and Non-Amnestic MCI when non-memory domain(s) was impaired.
Neuroimaging

Author Manuscript

MRI methods have been described in detail.15–17 Briefly, participants were imaged on a 1 or
1.5 Tesla Siemens Magnetom MRI scanner (see supplementary methods online). Threedimensional T1 and double echo proton density and T2 coronal images were acquired in 4mm contiguous slices. Images were analyzed with semi-automated segmentation methods
that have been previously described.16 Manual tracing was performed to determine total
intracranial volumes. Hippocampal and cerebral volumes were determined using automated
procedures described below.
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Hippocampal volume was computed using a standard atlas based diffeomorphic approach18
with label refinement modifications. Harmonized hippocampal masks developed through the
European Alzheimer’s Disease Consortium (EADC) and Alzheimer’s Disease
Neuroimaging Initiative (ADNI) Working Group on the Harmonized Protocol for Manual
Hippocampal Segmentation were used with the following procedures: 1) pre-processing with
extraction of intracranial cavity, non-uniformity correction, and tissue classification;19 2)
atlas registration of EADC-ADNI hippocampal masks;20 3) atlas fusion utilizing Multi-Atlas
Label Fusion;21 and 4) intensity-based label refinement.
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To segment WMH from other brain tissues, the first and second echo images from T2
sequences were summed and a log-normal distribution was fitted to the summed data (after
removal of CSF and correction of image intensity non-uniformities).22 A segmentation
threshold for WMH of 3.5 SD in voxel intensity greater than the mean of the fitted
distribution of brain parenchyma was applied.17 Brain infarcts were defined as areas of
abnormal signal intensity in a vascular distribution; 3mm or larger in size; with a CSF
density on the subtraction image (proton density minus T2 image); and for lesions in the
basal ganglia, distinct separation from the circle of Willis vessels.16,23
Statistical Analyses
Descriptive statistics were calculated using means and SDs, medians and interquartile
ranges, and frequency counts and percent. Continuous MRI measures were standardized to a
mean of zero and a SD of one to facilitate comparisons between measures. Natural log
transformation was used to improve distribution normality of WMH volume. MRI variables
were examined as both continuous and ordinal variables. Ordinal variables were examined

Alzheimer Dis Assoc Disord. Author manuscript; available in PMC 2019 January 01.

Bangen et al.

Page 5

Author Manuscript

given the possibility of nonlinear relationships between MRI variables and cognitive status/
cognitive outcome. For total cerebral brain volume and hippocampal volume, those in the
bottom quartile (with the smallest total cerebral brain volume and the smallest hippocampal
volume, respectively) were compared with those from the top three quartiles. For WMH
volume, those in the top quartile (with the greatest WMH volume) were compared with
those from the three bottom quartiles. Covert brain infarcts were categorized as present or
absent. Annualized change in MRI brain measures was calculated as the difference between
the raw MRI volumes from baseline to follow-up, divided by the follow-up period in years.
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Logistic regression models examined associations between MRI brain measures and
presence of MCI at baseline and follow-up. Logistic regression was used rather than survival
analysis given there were two time points for the MRI and neuropsychological data. Our
primary models were adjusted for age at MRI, years between MRI and neuropsychological
testing, education group (<high school degree, high school degree, some college, ≥college
degree), APOE ε4 status (carrier versus noncarrier), vascular risk factors (systolic blood
pressure, hypertension treatment, diabetes, current smoking, history of cardiovascular
disease and history of atrial fibrillation), and all other MRI variables. All models that
examined annualized change in MRI measures adjusted for the same variables as the logistic
regression analyses for baseline MRI variables described above and additionally adjusted for
baseline MRI measures. We additionally constructed models adjusted for demographics only
and adjusted for demographics, APOE ε4 status, and vascular risk factors (presented in the
online supplement). Overall, results from these models were similar to results from fully
adjusted models presented in our primary analysis. In addition, analyses were conducted
assessing whether there was an interaction between WMH volume and hippocampal volume
on presence of MCI or conversion from normal cognition to MCI. Secondary analyses were
performed restricting the MCI group to only those with amnestic MCI. In addition, brain
MRI were acquired using different MRI machine types that included differences in field
strength (i.e., 1 Tesla and 1.5 Tesla) and analyses were performed to assess the potential
confounding effects of these differences on MRI quantification. All analyses were performed
with Statistical Analyses System software version 9.4 (SAS Institute, Cary, NC). A p-value
of <0.05 was considered statistically significant.
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RESULTS
Participant characteristics
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Participant characteristics are presented in Table 1. At baseline, 22.5% of participants were
classified as MCI (17.4% amnestic MCI, 5.1% non-amnestic MCI). Longitudinal analyses,
which included those participants who were free of MCI at baseline, demonstrated that at
follow-up (average 6.5 years after baseline) 13.5% of participants had new onset MCI (9.8%
amnestic MCI, 3.7% non-amnestic MCI).
Cross-sectional associations of MRI markers with MCI
Table 2 presents cross-sectional associations between each MRI brain measure and MCI
status at baseline adjusting for demographic variables, APOE ε4 status, vascular risk factors,
and all other MRI measures. Being in the top quartile for WMH volume was associated with
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48% higher odds of MCI at baseline (OR=1.48, 95% CI:1.03–2.12, p-value=0.03). When the
MCI group was restricted to those with amnestic MCI, the odds ratio remained similar to
that observed for any MCI but the statistical significance was attenuated (p-value=0.05).
When WMH volume was examined as a continuous variable, there were trends toward
greater WMH volume being associated with higher odds of MCI (p-values ranged from 0.09
to 0.12).
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Being in the bottom quartile of hippocampal volume was associated with 58% higher odds
of MCI (OR=1.58, 95% CI:1.12–2.24, p-value=0.01) and 80% higher odds of MCI when the
MCI group was restricted to those with amnestic MCI (OR=1.80, 95% CI:1.23–2.64, pvalue=0.002). Similarly, when examined continuously, lower hippocampal volume was
significantly associated with higher odds of MCI. Neither total cerebral brain volume
(continuously or as quartiles) nor presence of covert brain infarcts were associated with the
presence of MCI at baseline. There was no interaction between WMH volume and
hippocampal volume on presence of MCI at baseline (p=0.99).
Longitudinal associations of baseline MRI markers with conversion to MCI at follow-up
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Table 3 shows the association between baseline MRI and conversion from normal cognition
to MCI at follow-up adjusting for demographic variables, APOE ε4 status, vascular risk
factors, and all other MRI measures. Higher WMH volume (being in the top quartile) at
baseline was associated with higher odds of conversion to MCI (OR=2.04, 95% CI:1.09–
3.79, p-value=0.03). When the MCI group was restricted to those with amnestic MCI,
findings were no longer statistically significant. When examined as a continuous variable,
baseline WMH volume was not associated with conversion to MCI at follow-up. Being in
the bottom quartile of hippocampal volume was associated with higher odds of MCI
(OR=2.13, 95% CI:1.14–3.96, p-value=0.02) and findings remained similar then the MCI
group was restricted to those with amnestic MCI only (OR=2.60, 95% CI:1.29–5.23, pvalue=0.007). Similarly, when examined continuously, lower hippocampal volume was
significantly associated with higher odds of MCI. Results remained similar when the MCI
group was restricted to those individuals with amnestic MCI. Total cerebral brain volume
(either continuously or as quartiles) and presence of brain infarcts were not associated with
conversion from normal cognition to MCI at follow-up. There was no significant interaction
between WMH volume and hippocampal volume on conversion to MCI at follow-up
(p=0.06).
Longitudinal associations of change in MRI markers between baseline and follow-up with
conversion to MCI at follow-up
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Table 4 presents longitudinal associations between annualized change in MRI brain
measures between baseline and follow-up and conversion to MCI adjusting for age at MRI,
years between baseline MRI and follow-up neuropsychological testing, education group,
APOE ε4 status, vascular risk, baseline MRI measures, and all other MRI measures. Change
in total cerebral brain volume, both continuously and as quartiles, was significantly
associated with conversion from normal cognition to MCI although findings were attenuated
when the MCI group was restricted to those with amnestic MCI. Change in continuous
hippocampal volume was associated with conversion to MCI when the MCI group was
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restricted to those with amnestic MCI (OR=0.68, 95% CI:0.48–0.96, p-value=0.03). There
were no significant associations between conversion from normal cognition to MCI and
annualized change in hippocampal volume as quartiles or WMH volumes (continuously or
as quartiles). The interaction between change in WMH volume and hippocampal volume on
conversion to MCI at follow-up was not significant (p=0.88).
Analyses to Examine Potential Bias across MRI Scanners and Field Strengths
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Brain MRI were acquired using different MRI machine types that included differences in
field strength (1 Tesla versus 1.5 Tesla). To assess the potential confounding effects of these
differences on MRI quantification, MRI machine, operating system and field strength were
added to age and gender estimates as predictors of the quantitative MRI measures included
in this study for all Framingham subjects studied during the period of observation of this
study. Adjusting for the multiple comparisons across regions, no significant effects of MRI
machine, operating system or field strength was found.

DISCUSSION

Author Manuscript

We found that baseline WMH and hippocampal volume were associated with presence of
MCI at baseline and associated with conversion from normal cognition to MCI at follow-up.
Annualized change from baseline to follow-up in total cerebral brain and hippocampal
volumes, but not WMH volume, was associated with conversion to MCI. This pattern of
findings raises the possibility that both cerebrovascular and neurodegenerative changes play
prominent roles prior to the development of frank cognitive impairment whereas
neurodegeneration may continue to play a larger role more proximal to conversion to MCI.
This pattern of findings is consistent with models and data indicating that cerebrovascular
changes, including WMH, play an important early role in individuals at risk for dementia5,24
as well as neuropathological data suggesting that AD-related neurodegeneration initially
occurs in MTL structures and progresses to more global involvement over time.3 Future
studies with additional time points are necessary to more fully examine this possibility.
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Although we found that baseline WMH volume was associated with baseline MCI status and
conversion from normal cognition to MCI at follow-up, we did not find associations between
increased WMH volume over time and higher odds of conversion to MCI. This contrasts
with other studies which have found that increased progression of WMH volume is
associated with conversion to MCI.25,26 Compared to the current study, participants in these
previous studies were older at baseline (mean age in 80s versus 60s), the follow-up period
was longer, and baseline WMH volume was higher. Differences in cohort characteristics and
study design may explain discrepancies in findings. Nonetheless, findings from these
previous studies and the current study provide support for the notion that WMH volume may
be useful in determining those at risk for later cognitive impairment and may inform
treatment strategies that would be useful prior to dementia onset.
In the current study, the effect of WMH was somewhat reduced when treating this variable
continuously rather than categorically suggesting the presence of a nonlinear relationship
whereby increased risk of MCI was particularly evident when comparing those in the
highest quartile of WMH volume compared to all other participants. This observation is
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consistent with other studies, including previous research from the FHS, indicating that
extensive WMH volume in particular may relate to decreased cognitive functioning.27 In
addition, for cross-sectional and longitudinal models the effect of WMH was attenuated
when the analyses where restricted to amnestic MCI whereas hippocampal volume was
significantly associated with MCI status in the whole sample as well as when the MCI
sample was restricted to amnestic MCI. This pattern of findings may relate to reduced
power. Amnestic and non-amnestic MCI have been linked to different underlying etiologies
although it should be noted that amnestic MCI is not specific to a pre-AD condition and
vascular disease has been associated with memory impairment. Findings related to WMH
have been mixed with some studies demonstrating that non-amnestic MCI subgroups have
greater WMH volume relative to MCI subgroups characterized by memory deficits6 whereas
other studies have found that amnestic MCI subgroups show greater WMH burden relative
to non-amnestic MCI.28 Other studies have provided evidence for a threshold effect whereby
small-vessel cerebrovascular disease may induce specific patterns of cognitive impairment.7
Given the small number of participants characterized as non-amnestic MCI, we did not
conduct separate analyses for this subtype.
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Although MCI is associated with greater vascular risk burden29 and small-vessel
cerebrovascular disease,6,30 prevailing models of AD pathogenesis31 and proposed research
biomarkers of MCI32 do not yet formally integrate either MRI evidence of cerebrovascular
disease or cerebrovascular risk factors in their models or conceptualizations. Although there
are no widely accepted criteria for determining biomarker positivity for cerebrovascular
disease, there is a need to develop such methodologies. A metric has recently been proposed
to identify participants with cerebrovascular imaging abnormalities based on a combination
of infarcts and WMH burden in the context of absence or presence of amyloid elevation.33
Further research is needed to clarify the link between small-vessel cerebrovascular disease
and MCI, particularly in light of evidence that vascular changes may precede neuronal
dysfunction and may initiate and exacerbate neurodegeneration.24,34 Our work has shown
that small-vessel cerebrovascular disease increases AD risk,13 relates to heterogeneity
among MCI phenotypic subgroups,6,28 predicts disease course in prodromal dementia,5 and
is more reliably associated with markers of neurodegeneration than are measures of Aβ.35
Whether or not WMH represents a pathogenic factor of AD per se, it is clear that smallvessel cerebrovascular disease is an important component of the clinical expression of the
disease, which has implications not only for models of AD pathophysiology and diagnostic
criteria but also for treatment.13 Given that traditional vascular risk factors are known risk
factors for the development of WMH pathology, aggressive efforts to prevent and manage
these risk factors may reduce risk for MCI and AD.
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We excluded individuals with clinical stroke, suggesting that even subclinical
cerebrovascular changes play an important role in the expression and evolution of MCI. The
notion is in line with our previous work showing that, in a sample of autopsy-confirmed AD
patients, the presence of mild cerebrovascular changes was associated with less severe AD
pathology yet there were no differences in severity of cognitive impairment between the AD
patients with and without evidence of cerebrovascular disease.36 These findings raise the
possibility that cerebrovascular pathology contributes to overall severity of cognitive
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impairment, even in patients with autopsy-confirmed AD and relatively mild cerebrovascular
disease.36
The lack of consensus for defining MCI may contribute to uncertainty regarding the optimal
biomarkers for prodromal AD. Our previous work showing that actuarial clinical diagnostic
decision-making using a full range of neuropsychological test measures provides more
nuanced MCI distinctions and leads to tighter associations with respect to biomarkers related
to cognitive impairment as well as progression to dementia.37 In the current study, we
applied rigorous actuarial MCI criteria and MCI conversion was associated with MRI
markers of small vessel cerebrovascular disease, providing further support for the
involvement of WMH in MCI.
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Strengths of the current study include the large, well-characterized, community-based
sample; prospective study design; and ongoing follow-up for several years. The present
findings extend previous FHS results showing associations of WMH volume with decreased
cognitive performance27 and incident MCI38 by incorporating rigorous actuarial
neuropsychological criteria for MCI, excluding those with history of clinical stroke or
dementia, examining longitudinal change in MRI volume, and including MRI markers of
neurodegeneration (i.e., hippocampal volume). We found that baseline measures of both
WMH volume and hippocampal volume contributed to new onset MCI.
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There are limitations to the present findings. We assessed two MRI markers of
cerebrovascular changes and neurodegeneration each and did not examine additional
markers that may relate to MCI (e.g., microinfarcts, tau, cortical thickness). A recent
multimodal study suggested that the influence of WMH volume on cognition may be
mediated by clinically covert processes, such as microinfarcts.39 In addition, hippocampal
volume has been associated with non-neurodegenerative pathologies including subcortical
cerebrovascular disease.40 Future research integrating additional markers of
neurodegeneration such as AD-related patterns of cortical thickness may be more specific to
neurodegeneration than hippocampal volume alone. Notably, participants included in the
longitudinal study sample were younger, had completed more education, and had lower
vascular risk burden than those who were not included in the longitudinal sample and who
were also free of MCI at baseline (Table s1). Despite heterogeneity in cognitive
characterization, our sample was generally well-educated, medically healthy, and had
relatively low WMH burden, which may have attenuated our ability to detect group
differences. The magnitude of effects of our findings may have differed in a sample with
greater vascular risk, use of a T2-weighted fluid attenuated inversion recovery (FLAIR) to
quantify WMH, and a more heterogeneous group of MCI participants that did not include
predominantly amnestic MCI. For instance, we found trends toward associations between
the presence of covert brain infarcts and MCI at baseline as well as conversion from normal
cognition to MCI at follow-up. These associations may have been statistically significant in
a cohort with greater burden of cerebrovascular disease.
Despite these limitations, in the search for reliable biomarkers of MCI and dementia risk, in
addition to assessment of medial temporal lobe volume and neurodegeneration,
consideration of WMH may prove useful. The combination of white matter markers with
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additional biomarkers (e.g., CSF amyloid, hippocampal volume) as well as consideration of
MCI clinical subtypes (e.g., amnestic, non-amnestic) may more completely inform the AD
and cerebrovascular contributions to the dementia prodrome. In summary, our results show
that small-vessel cerebrovascular disease increases risk for MCI, a known risk factor for
subsequent transition to dementia. Our findings suggest that hippocampal atrophy and
WMHs are useful biomarkers associated with conversion to MCI. Our findings extend
earlier results highlighting the association between WMH and risk of AD to conversion from
normal cognition to MCI.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.

Author Manuscript

Acknowledgments
Source of Funding: This research was made possible by the Framingham Heart Study’s National Heart, Lung, and
Blood Institute contract (NIH/NHLBI Contract #N01-HC-25195), grants from the National Institutes of Health
(R01 AG049810, R01 AG08122, R01 AG033040, P30 AG010129), VA Clinical Science Research & Development
(Career Development Award-2 1IK2CX000938 to KJB), and the Alzheimer’s Association (NIRG-15-364251 to
KJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of
the National Institute of Neurological Disorders and Stroke, the National Heart Lung and Blood Institute, the VA,
Alzheimer’s Association, or the NIH.

References

Author Manuscript
Author Manuscript

1. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of
Alzheimer’s disease in memory-impaired individuals. JAMA. 1995; 273(16):1274–1278. [PubMed:
7646655]
2. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer
disease and mild cognitive impairment. Ann Neurol. 2009; 66(2):200–208. [PubMed: 19743450]
3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol.
1991; 82(4):239–259. [PubMed: 1759558]
4. Brickman AM, Zahodne LB, Guzman VA, et al. Reconsidering harbingers of dementia: progression
of parietal lobe white matter hyperintensities predicts Alzheimer’s disease incidence. Neurobiol
Aging. 2015; 36(1):27–32. [PubMed: 25155654]
5. Tosto G, Zimmerman ME, Carmichael OT, Brickman AM. Predicting aggressive decline in mild
cognitive impairment: the importance of white matter hyperintensities. JAMA neurology. 2014;
71(7):872–877. [PubMed: 24821476]
6. Delano-Wood L, Bondi MW, Sacco J, et al. Heterogeneity in mild cognitive impairment: differences
in neuropsychological profile and associated white matter lesion pathology. J Int Neuropsychol Soc.
2009; 15(6):906–914. [PubMed: 19891820]
7. Libon DJ, Price CC, Giovannetti T, et al. Linking MRI hyperintensities with patterns of
neuropsychological impairment: evidence for a threshold effect. Stroke. 2008; 39(3):806–813.
[PubMed: 18258842]
8. Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A. Regional white matter
pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological
functioning. Stroke. 2008; 39(3):794–799. [PubMed: 18258826]
9. Jak AJ, Urban S, McCauley A, et al. Profile of hippocampal volumes and stroke risk varies by
neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009; 15(6):
890–897. [PubMed: 19570306]
10. Jak AJ, Bondi MW, Delano-Wood L, et al. Quantification of five neuropsychological approaches to
defining mild cognitive impairment. Am J Geriatr Psychiatry. 2009; 17(5):368–375. [PubMed:
19390294]

Alzheimer Dis Assoc Disord. Author manuscript; available in PMC 2019 January 01.

Bangen et al.

Page 11

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

11. Heaton, RK., Grant, I., Matthews, CG. Comprehensive norms for an expanded Halstead-Reitan
Battery: Demographic corrections, research findings, and clinical applications. Odessa, Florida:
Psychological Assessment Resources; 1991.
12. Bondi MW, Smith GE. Mild cognitive impairment: a concept and diagnostic entity in need of input
from neuropsychology. Journal of the International Neuropsychological Society. 2014; 20(2):129–
134. [PubMed: 24490866]
13. Brickman AM, Provenzano FA, Muraskin J, et al. Regional White Matter Hyperintensity Volume,
Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the Community. Arch Neurol.
2012:1–7.
14. Jak AJ, Preis SR, Beiser AS, et al. Neuropsychological Criteria for Mild Cognitive Impairment and
Dementia Risk in the Framingham Heart Study. J Int Neuropsychol Soc. 2016:1–7.
15. Debette S, Beiser A, Hoffmann U, et al. Visceral fat is associated with lower brain volume in
healthy middle-aged adults. Ann Neurol. 2010; 68(2):136–144. [PubMed: 20695006]
16. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the
framingham heart study: establishing what is normal. Neurobiol Aging. 2005; 26(4):491–510.
[PubMed: 15653178]
17. Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity
volume: the Framingham Study. Stroke. 2004; 35(8):1857–1861. [PubMed: 15218158]
18. Vercauteren T, Pennec X, Perchant A, Ayache N. Non-parametric diffeomorphic image registration
with the demons algorithm. Medical image computing and computer-assisted intervention :
MICCAI International Conference on Medical Image Computing and Computer-Assisted
Intervention. 2007; 10(Pt 2):319–326.
19. Fletcher E, Singh B, Harvey D, Carmichael O, DeCarli C. Adaptive image segmentation for robust
measurement of longitudinal brain tissue change. Conference proceedings : … Annual
International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE
Engineering in Medicine and Biology Society. Annual Conference. 2012; 2012:5319–5322.
20. Boccardi M, Bocchetta M, Ganzola R, et al. Operationalizing protocol differences for EADCADNI manual hippocampal segmentation. Alzheimer’s & dementia : the journal of the
Alzheimer’s Association. 2015; 11(2):184–194.
21. Wang H, Suh JW, Das SR, Pluta JB, Craige C, Yushkevich PA. Multi-Atlas Segmentation with
Joint Label Fusion. IEEE transactions on pattern analysis and machine intelligence. 2013; 35(3):
611–623. [PubMed: 22732662]
22. DeCarli C, Murphy DG, Teichberg D, Campbell G, Sobering GS. Local histogram correction of
MRI spatially dependent image pixel intensity nonuniformity. J Magn Reson Imaging. 1996; 6(3):
519–528. [PubMed: 8724419]
23. Das RR, Seshadri S, Beiser AS, et al. Prevalence and correlates of silent cerebral infarcts in the
Framingham offspring study. Stroke. 2008; 39(11):2929–2935. [PubMed: 18583555]
24. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other
disorders. Nature reviews Neuroscience. 2011; 12(12):723–738. [PubMed: 22048062]
25. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter
hyperintensity progression matters. Neurology. 2009; 73(2):120–125. [PubMed: 19597134]
26. Silbert LC, Dodge HH, Perkins LG, et al. Trajectory of white matter hyperintensity burden
preceding mild cognitive impairment. Neurology. 2012; 79(8):741–747. [PubMed: 22843262]
27. Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with
decreased cognitive functioning: the Framingham Heart Study. Arch Neurol. 2006; 63(2):246–250.
[PubMed: 16476813]
28. Luchsinger JA, Brickman AM, Reitz C, et al. Subclinical cerebrovascular disease in mild cognitive
impairment. Neurology. 2009; 73(6):450–456. [PubMed: 19667320]
29. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild
cognitive impairment. Arch Neurol. 2007; 64(4):570–575. [PubMed: 17420320]
30. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain
morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood
Institute Twin Study. Arch Neurol. 2001; 58(4):643–647. [PubMed: 11295996]

Alzheimer Dis Assoc Disord. Author manuscript; available in PMC 2019 January 01.

Bangen et al.

Page 12

Author Manuscript
Author Manuscript

31. Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s
disease: an updated hypothetical model of dynamic biomarkers. The Lancet Neurology. 2013;
12(2):207–216. [PubMed: 23332364]
32. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to
Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s
Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s &
dementia : the journal of the Alzheimer’s Association. 2011; 7(3):270–279.
33. Vemuri P, Knopman DS. The role of cerebrovascular disease when there is concomitant Alzheimer
disease. Biochim Biophys Acta. 2016; 1862(5):952–956. [PubMed: 26408957]
34. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via
cyclophilin A. Nature. 2012; 485(7399):512–516. [PubMed: 22622580]
35. Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM. White matter
hyperintensities and amyloid are independently associated with entorhinal cortex volume among
individuals with mild cognitive impairment. Alzheimer’s & dementia : the journal of the
Alzheimer’s Association. 2013; 9(5 Suppl):S124–131.
36. Bangen KJ, Nation DA, Delano-Wood L, et al. Aggregate effects of vascular risk factors on
cerebrovascular changes in autopsy-confirmed Alzheimer’s disease. Alzheimer’s & dementia : the
journal of the Alzheimer’s Association. 2015; 11(4):394–403.e391.
37. Bondi MW, Edmonds EC, Jak AJ, et al. Neuropsychological criteria for mild cognitive impairment
improves diagnostic precision, biomarker associations, and progression rates. Journal of
Alzheimer’s disease : JAD. 2014; 42(1):275–289. [PubMed: 24844687]
38. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with
incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring
Study. Stroke. 2010; 41(4):600–606. [PubMed: 20167919]
39. Knopman DS, Griswold ME, Lirette ST, et al. Vascular imaging abnormalities and cognition:
mediation by cortical volume in nondemented individuals: atherosclerosis risk in communitiesneurocognitive study. Stroke. 2015; 46(2):433–440. [PubMed: 25563642]
40. Du AT, Schuff N, Laakso MP, et al. Effects of subcortical ischemic vascular dementia and AD on
entorhinal cortex and hippocampus. Neurology. 2002; 58(11):1635–1641. [PubMed: 12058091]

Author Manuscript
Author Manuscript
Alzheimer Dis Assoc Disord. Author manuscript; available in PMC 2019 January 01.

Bangen et al.

Page 13

Table 1

Author Manuscript

Participant characteristics
Cross-Sectional Study Samplea
(N=1049)

Longitudinal Study Sampleb
(N=561)

68.6 (5.7)

67.8 (5.4)

131 (19)

129 (18)

0.0 (0.0, 0.0)

—

Years between baseline MRI and follow-up neuropsychological
assessment

—

6.5 (6.0, 6.9)

Days between follow-up MRI and follow-up neuropsychological
assessment

—

0.0 (0.0, 0.0)

Years between baseline MRI and follow-up MRI

—

6.5 (5.9, 6.9)

556 (53.0)

306 (54.6)

<High school degree

43 (4.1)

15 (2.7)

High school degree

336 (32.0)

173 (30.8)

Some college

322 (30.7)

171 (30.5)

≥College degree

348 (33.2)

202 (36.0)

APOE ε4 allele

225 (21.9)

120 (21.8)

Diabetes

144 (14.0)

57 (10.3)

84 (8.0)

32 (5.7)

Hypertension treatment

422 (40.2)

199 (35.5)

History of cardiovascular disease

152 (14.5)

65 (11.6)

Continuous characteristics, mean (SD)
Age at baseline MRI (years)
Systolic blood pressure (mm Hg)

Continuous characteristics, median

(25th,

75th

percentile)

Days between baseline MRI and baseline neuropsychological
assessment

Author Manuscript

Categorical characteristics, n (%)
Women
Education Group

Current smoker

Author Manuscript

History of atrial fibrillation
Any MCI diagnosis at baseline
Amnestic MCI
Non-Amnestic MCI
Any MCI diagnosis at follow-up
Amnestic MCI
Non-Amnestic MCI

MRI measures at baseline, median
Total cranial volume

(25th

percentile,

75th

52 (5.0)

19 (3.4)

236 (22.5)

0 (0.00)

183 (17.4)

0 (0.00)

53 (5.1)

0 (0.00)

—

72 (12.8)

—

52 (72.2)

—

20 (27.8)

1239 (1148, 1332)

1239 (1151, 1337)

percentile)

(cm3)

Author Manuscript

Total cerebral brain volume (%)
White matter hyperintensities volume (%)
Hippocampal volume (%)
Covert brain infarct (present), n (%)

78.3 (76.2, 80.4)

78.7 (76.8, 80.6)

0.067 (0.036, 0.13)

0.060 (0.035, 0.11)

0.53 (0.49, 0.56)

0.53 (0.50, 0.56)

133 (12.7)

61 (10.9)

Annualized change in MRI measures between baseline and follow-up,
median (25th percentile, 75th percentile)
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Cross-Sectional Study Samplea
(N=1049)

Longitudinal Study Sampleb
(N=561)

Total cerebral brain volume (cm3/year)

—

−7.02 (−9.53, −4.24)

White matter hyperintensities volume (cm3/year)

—

0.15 (0.052, 0.33)

Hippocampal volume (cm3/year)

—

−0.010 (−0.035, 0.013)

Cross-sectional analysis includes participants who have MRI and neuropsychological data at baseline.

b

Longitudinal analysis includes participants who were free of MCI at baseline and had neuropsychological data available at follow-up.

Note that MRI variables expressed as percent are normalized by total intracranial volume to correct for head size.

Author Manuscript
Author Manuscript
Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript
1.46 (0.95–2.23)

1.58 (1.12–2.24)

Q1 vs Q234
Present vs Absent

0.79 (0.67–0.94)

1.48 (1.03–2.12)

Q4 vs Q123
Continuous
(Per SD increment)a

1.14 (0.97–1.35)

1.07 (0.73–1.59)

Q1 vs Q234
Continuous
(Per SD increment)a

1.04 (0.86–1.26)

OR (95% CI)

Any MCI
(N=236)

Continuous
(Per SD increment)a

Classification

0.08

0.01

0.007

0.03

0.12

0.72

0.68

P-value

1.55 (0.97–2.47)

1.80 (1.23–2.64)

0.72 (0.60–0.86)

1.49 (0.99–2.23)

1.17 (0.97–1.42)

0.83 (0.53–1.30)

1.13 (0.92–1.40)

OR (95% CI)

0.06

0.002

0.0005

0.05

0.09

0.41

0.24

P-value

Amnestic MCI
(N=183)

Statistically significant findings (p < 0.05) appear in bold font.

Note that MRI variables expressed as percent are normalized by total intracranial volume to correct for head size.

a
Standard deviation increment calculated using the entire sample.

All models are adjusted for age at MRI, sex, days between baseline MRI and baseline neuropsychological assessment, education group (<high school degree, high school degree, some college, ≥college
degree), APOE ε4 status (carrier versus noncarrier) vascular risk factors (systolic blood pressure, hypertension treatment, diabetes, smoking, history of cardiovascular disease, history of atrial fibrillation),
and all of the other MRI measures (continuous) listed in the table.

Covert brain infarct

Hippocampal volume (%)

Ln white matter hyperintensities volume (%)

Total cerebral brain volume (%)

Baseline MRI Measure

MCI Outcome (versus no MCI)

Cross-sectional association between baseline MRI brain measures and presence of MCI (N=1049)

Author Manuscript
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Author Manuscript

Author Manuscript

Author Manuscript
0.39 (0.14–1.08)

2.13 (1.14–3.96)

Q1 vs Q234
Present vs Absent

0.62 (0.46–0.85)

2.04 (1.09–3.79)

Q4 vs Q123
Continuous
(Per SD increment)a

1.20 (0.89–1.61)

1.16 (0.60–2.26)

Q1 vs Q234
Continuous
(Per SD increment) a

1.20 (0.85–1.70)

OR (95% CI)

Any MCI
(N=72)

Continuous
(Per SD increment)a

Classification

0.07

0.02

0.003

0.03

0.23

0.66

0.31

P-value

0.24 (0.05–1.06)

2.60 (1.29–5.23)

0.58 (0.41–0.83)

1.73 (0.83–3.63)

1.14 (0.81–1.61)

1.15 (0.53–2.51)

1.24 (0.83–1.87)

OR (95% CI)

0.06

0.007

0.003

0.14

0.46

0.73

0.30

P-value

Amnestic MCI
(N=52)

Statistically significant findings (p < 0.05) appear in bold font.

Note that MRI variables expressed as percent are normalized by total intracranial volume to correct for head size.

a
Standard deviation increment calculated using the entire sample.

Models are adjusted for age at MRI, sex, years between MRI and neuropsychological assessment, education group (<high school degree, high school degree, some college, ≥college degree), APOE ε4 status
(carrier versus noncarrier), vascular risk factors (systolic blood pressure, hypertension treatment, diabetes, smoking, history of cardiovascular disease, history of atrial fibrillation), and all other MRI
measures (continuous) listed in the table.

Covert brain infarct

Hippocampal volume (%)

Ln white matter hyperintensities volume (%)

Total cerebral brain volume (%)

Baseline MRI Measure

MCI Outcome (versus no MCI)

Association between baseline MRI brain measures and presence of MCI at follow-up (N=561).
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(cm3/year)

0.77 (0.56–1.04)
1.31 (0.66–2.60)

Q1 vs Q234

1.33 (0.67–2.65)

Q4 vs Q123
Continuous
(Per SD increment)a

0.94 (0.69–1.27)

3.03 (1.50–6.10)

Q1 vs Q234
Continuous
(Per SD increment)a

0.64 (0.46–0.88)

OR (95% CI)

Any MCI
(N=56)

0.44

0.09

0.42

0.69

0.002

0.007

P-value

1.64 (0.77–3.49)

0.68 (0.48–0.96)

1.17 (0.54–2.53)

0.92 (0.67–1.28)

2.69 (1.20–5.99)

0.73 (0.52–1.03)

OR (95% CI)

0.20

0.03

0.70

0.63

0.02

0.07

P-value

Amnestic MCI
(N=42)

MCI Outcome (versus no MCI)

Continuous
(Per SD increment)a

Classification

Note: Annualized change in MRI brain measures was calculated as the difference between the raw MRI volumes from baseline to follow-up, divided by the follow-up period (in years). Individuals with MCI
at baseline are excluded from the analysis. In addition, 70 participants from the longitudinal study sample did not complete a follow-up MRI and thus were not included in the analysis of annualized change
in MRI measures.

a
Standard deviation increment calculated using the entire sample

Models are adjusted for age at MRI, sex, years between baseline MRI and follow-up neuropsychological assessment, education group (<high school degree, high school degree, some college, ≥college
degree), APOE ε4 status (carrier versus noncarrier), vascular risk factors (systolic blood pressure, hypertension treatment, diabetes, smoking, history of cardiovascular disease, history of atrial fibrillation),
baseline brain MRI volume, and the other MRI measures (continuous) listed in the table.

Hippocampal volume

(cm3/year)

Ln white matter hyperintensities volume

Total cerebral brain volume (cm3/year)

Annualized change in MRI Measure between Baseline and Follow-up

Association between annualized change in MRI brain measures between baseline and follow-up and presence of MCI at follow-up (N=491).
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